USD 14.59
(-3.06%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 35.96 Million | 90 Million | 65.16 Million | 52.8 Million | 11.18 Million | 9.36 Million |
Net Income | -110.08 Million | -141.3 Million | -75.18 Million | -24.08 Million | -32.6 Million | -36.25 Million |
Depreciation & Amortization | 50.29 Million | 54.83 Million | 47.06 Million | 38.51 Million | 36.8 Million | 33.91 Million |
Deferred income taxes | -1.97 Million | -2.95 Million | -5.64 Million | -10.31 Million | -11.24 Million | -12.55 Million |
Stock-based compensation | 101 Million | 109.17 Million | 35.8 Million | 6.74 Million | 2.46 Million | 2.31 Million |
Change in working capital | -33.32 Million | 40.75 Million | 36.4 Million | 28.47 Million | 8.2 Million | 17.98 Million |
Other non-cash items | 30.05 Million | 29.5 Million | 26.72 Million | 13.47 Million | 7.55 Million | 3.95 Million |
Investing Cash Flow | -22.47 Million | -34.78 Million | -387.41 Million | -6.87 Million | -47.36 Million | -5.8 Million |
Investments in PPE | -2.93 Million | -7.72 Million | -9.75 Million | -4.36 Million | -7.19 Million | -2.9 Million |
Acquisitions | -18.79 Million | -23.81 Million | -352.71 Million | -2.51 Million | -40.17 Million | -2.89 Million |
Investment purchases | -750 Thousand | -3.1 Million | - | - | - | - |
Sales/Maturities of investments | 19.54 Million | - | - | - | - | - |
Other Investing Activities | -19.53 Million | -139 Thousand | -24.95 Million | 4000.00 | - | -8.71 Million |
Financing Cash Flow | 5.32 Million | 261 Thousand | 305.52 Million | 115.96 Million | 29.37 Million | 1.77 Million |
Debt repayment | - | - | -250 Million | -205 Million | -28.45 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -36.03 Million | - | - | - |
Common Stock Issuance | 6.04 Million | 5.2 Million | 10.14 Million | 328.54 Million | 923 Thousand | 1.77 Million |
Other Financing Activities | -721 Thousand | -4.94 Million | 607.29 Million | -7.58 Million | 56.9 Million | 1.77 Million |
Accounts receivables | -19.23 Million | -9.48 Million | -6.52 Million | -23.11 Million | -14.46 Million | -3.35 Million |
Accounts payables | 9.35 Million | 5.89 Million | 2.06 Million | 4.02 Million | 1.29 Million | -313 Thousand |
Inventory | - | - | -4.95 Million | 3.77 Million | 869 Thousand | 3.37 Million |
Other working capital | -23.44 Million | 44.34 Million | 45.81 Million | 43.78 Million | 20.5 Million | 18.27 Million |
Cash at beginning of period | 224.72 Million | 177.15 Million | 194.86 Million | 32.37 Million | 39.24 Million | 33.91 Million |
Cash at end of period | 247.2 Million | 231.92 Million | 177.15 Million | 194.86 Million | 32.43 Million | 39.24 Million |
Capital Expenditure | -2.93 Million | -7.72 Million | -9.75 Million | -4.36 Million | -7.19 Million | -2.9 Million |
Effect of forex changes on cash | 79 Thousand | -713 Thousand | -993 Thousand | 604 Thousand | - | - |
Net cash flow / Change in cash | 22.48 Million | 54.77 Million | -17.71 Million | 162.49 Million | -6.8 Million | 5.32 Million |
Free Cash Flow | 33.03 Million | 82.27 Million | 55.41 Million | 48.43 Million | 3.99 Million | 6.45 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -19.26 Million | -20.52 Million | -110.08 Million | -17.41 Million | -32.27 Million | -36.19 Million |
Depreciation & Amortization | 11.87 Million | 11.99 Million | 50.29 Million | 12.69 Million | 12.76 Million | 12.41 Million |
Deferred income taxes | -250 Thousand | -267 Thousand | -1.97 Million | -3000.00 | -1.61 Million | -328 Thousand |
Stock-based compensation | 26.28 Million | 20.57 Million | 101 Million | 22.91 Million | 28.34 Million | 30.18 Million |
Change in working capital | -12.57 Million | -36.09 Million | -33.32 Million | -9.45 Million | 15.85 Million | -884 Thousand |
Other non-cash items | 72.05 Million | 45.95 Million | 30.05 Million | 7.17 Million | 10.2 Million | 6.38 Million |
Investing Cash Flow | -2.3 Million | -3.23 Million | -22.47 Million | -393 Thousand | -19.52 Million | -704 Thousand |
Investments in PPE | -978 Thousand | -1.75 Million | -2.93 Million | -412 Thousand | -736 Thousand | -665 Thousand |
Acquisitions | - | - | -18.79 Million | - | -18.79 Million | - |
Investment purchases | -1 Million | -1.5 Million | -750 Thousand | - | - | - |
Sales/Maturities of investments | - | - | 19.54 Million | - | - | - |
Other Investing Activities | -330 Thousand | 25 Thousand | -19.53 Million | 19 Thousand | 11 Thousand | -39 Thousand |
Financing Cash Flow | -37.67 Million | 280 Thousand | 5.32 Million | 164 Thousand | 2.67 Million | -35 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -35.35 Million | - | - | - | - | - |
Common Stock Issuance | 1.27 Million | 280 Thousand | 6.04 Million | 402 Thousand | 2.67 Million | 242 Thousand |
Other Financing Activities | -3.6 Million | 280 Thousand | -721 Thousand | -238 Thousand | 2.67 Million | -277 Thousand |
Accounts receivables | -13.76 Million | 12.69 Million | -19.23 Million | -12.72 Million | 5.53 Million | -15.96 Million |
Accounts payables | -1.55 Million | -5.67 Million | 9.35 Million | 4.43 Million | 5.39 Million | 92 Thousand |
Inventory | - | - | - | 727 Thousand | 2.69 Million | 11.46 Million |
Other working capital | 2.74 Million | -43.11 Million | -23.44 Million | -1.9 Million | 2.23 Million | 3.52 Million |
Cash at beginning of period | 231.77 Million | 247.2 Million | 224.72 Million | 231.25 Million | 218.7 Million | 207.82 Million |
Cash at end of period | 204.51 Million | 231.77 Million | 247.2 Million | 247.2 Million | 234.85 Million | 218.7 Million |
Capital Expenditure | -978 Thousand | -1.75 Million | -2.93 Million | -412 Thousand | -736 Thousand | -665 Thousand |
Effect of forex changes on cash | -32 Thousand | -184 Thousand | 79 Thousand | 269 Thousand | -282 Thousand | 50 Thousand |
Net cash flow / Change in cash | -27.25 Million | -15.43 Million | 22.48 Million | 15.95 Million | 16.14 Million | 10.88 Million |
Free Cash Flow | 11.78 Million | -17.65 Million | 33.03 Million | 15.5 Million | 32.54 Million | 10.9 Million |
4829
SOAG
8215
ONWARDTEC
LYPSAGEMS
POCI